Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 11290849)

Published in Alcohol Clin Exp Res on March 01, 2001

Authors

N E Badia-Elder1, R B Stewart, T A Powrozek, K F Roy, J M Murphy, T K Li

Author Affiliations

1: Department of Psychology, Purdue School of Science, IUPUI, Indiana University School of Medicine, Indianapolis 46202, USA. nbadiael@iupui.edu

Articles citing this

A role for brain stress systems in addiction. Neuron (2008) 4.71

Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J Clin Invest (2005) 1.57

Neuroscience of alcoholism: molecular and cellular mechanisms. Cell Mol Life Sci (2009) 1.32

Neuropeptide Y in the central nucleus of the amygdala suppresses dependence-induced increases in alcohol drinking. Pharmacol Biochem Behav (2008) 1.23

Viral vector-induced amygdala NPY overexpression reverses increased alcohol intake caused by repeated deprivations in Wistar rats. Brain (2007) 1.14

Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity. Pharmacol Biochem Behav (2012) 1.13

Neuropeptide Y (NPY) suppresses yohimbine-induced reinstatement of alcohol seeking. Psychopharmacology (Berl) (2009) 1.12

Tobacco addiction and the dysregulation of brain stress systems. Neurosci Biobehav Rev (2012) 1.09

Functional NPY variation as a factor in stress resilience and alcohol consumption in rhesus macaques. Arch Gen Psychiatry (2010) 1.05

Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence. Alcohol Clin Exp Res (2008) 1.04

Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors. Neuropsychopharmacology (2012) 0.99

Candidate genes for alcohol preference identified by expression profiling in alcohol-preferring and -nonpreferring reciprocal congenic rats. Genome Biol (2010) 0.96

Comparison of basal neuropeptide Y and corticotropin releasing factor levels between the high ethanol drinking C57BL/6J and low ethanol drinking DBA/2J inbred mouse strains. Alcohol Clin Exp Res (2005) 0.92

Neuropeptide Y signaling in the central nucleus of amygdala regulates alcohol-drinking and anxiety-like behaviors of alcohol-preferring rats. Alcohol Clin Exp Res (2009) 0.91

Effects of hindbrain melanin-concentrating hormone and neuropeptide Y administration on licking for water, saccharin, and sucrose solutions. Am J Physiol Regul Integr Comp Physiol (2007) 0.89

Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring rats. Biol Psychiatry (2013) 0.88

Effect of polymorphism on expression of the neuropeptide Y gene in inbred alcohol-preferring and -nonpreferring rats. Neuroscience (2005) 0.88

Similarities in hypothalamic and mesocorticolimbic circuits regulating the overconsumption of food and alcohol. Physiol Behav (2011) 0.88

Neuropeptide Y administration into the amygdala suppresses ethanol drinking in alcohol-preferring (P) rats following multiple deprivations. Pharmacol Biochem Behav (2008) 0.87

Effects of histone deacetylase inhibitors on amygdaloid histone acetylation and neuropeptide Y expression: a role in anxiety-like and alcohol-drinking behaviours. Int J Neuropsychopharmacol (2014) 0.87

Neuropeptide Y suppresses ethanol drinking in ethanol-abstinent, but not non-ethanol-abstinent, Wistar rats. Alcohol (2008) 0.87

Elevated anxiety-like behavior following ethanol exposure in mutant mice lacking neuropeptide Y (NPY). Drug Alcohol Depend (2007) 0.86

Neuropeptide Y (NPY) in the extended amygdala is recruited during the transition to alcohol dependence. Neuropeptides (2012) 0.82

Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use. ILAR J (2012) 0.81

Peripheral and central administration of a selective neuropeptide Y Y1 receptor antagonist suppresses ethanol intake by C57BL/6J mice. Alcohol Clin Exp Res (2004) 0.81

Effects of neuropeptide Y and ethanol on arousal and anxiety-like behavior in alcohol-preferring rats. Alcohol (2010) 0.80

Neuropeptide Y (NPY)-induced reductions in alcohol intake during continuous access and following alcohol deprivation are not altered by restraint stress in alcohol-preferring (P) rats. Pharmacol Biochem Behav (2010) 0.80

Neuropeptide Y (NPY) in the central nucleus of the amygdala (CeA) does not affect ethanol-reinforced responding in binge-drinking, nondependent rats. Pharmacol Biochem Behav (2011) 0.78

Rodent models and mechanisms of voluntary binge-like ethanol consumption: Examples, opportunities, and strategies for preclinical research. Prog Neuropsychopharmacol Biol Psychiatry (2015) 0.77

Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders. Front Neurosci (2014) 0.76

Npy deletion in an alcohol non-preferring rat model elicits differential effects on alcohol consumption and body weight. J Genet Genomics (2016) 0.75

Behavioral Neuroadaptation to Alcohol: From Glucocorticoids to Histone Acetylation. Front Psychiatry (2016) 0.75

Articles by these authors

Performance of a five-item mental health screening test. Med Care (1991) 8.76

Uncertainty in predictions of the climate response to rising levels of greenhouse gases. Nature (2005) 7.46

Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet (1998) 6.04

Performance of screening and diagnostic tests. Application of receiver operating characteristic analysis. Arch Gen Psychiatry (1987) 4.62

Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng (1998) 4.54

A review of medication errors and compliance in ambulant patients. Clin Pharmacol Ther (1972) 4.40

Alcoholism susceptibility loci: confirmation studies in a replicate sample and further mapping. Alcohol Clin Exp Res (2000) 3.42

A genome screen of maximum number of drinks as an alcoholism phenotype. Am J Med Genet (2000) 3.14

Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol (1998) 3.07

Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res (2001) 3.06

Drug-induced illness leading to hospitalization. JAMA (1974) 3.02

Mind and mood in modern art, II: Depressive disorders, spirituality, and early deaths in the abstract expressionist artists of the New York School. Am J Psychiatry (1994) 2.85

Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet (1991) 2.75

Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism. Am J Hum Genet (1999) 2.73

Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol (2007) 2.65

Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res (1998) 2.60

Protecting severely abused and neglected children. An unkept promise. N Engl J Med (1990) 2.58

Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant. J Clin Invest (1989) 2.44

Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol (2001) 2.41

Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res (1999) 2.26

Use of the Pediatric Symptom Checklist to screen for psychosocial problems in pediatric primary care: a national feasibility study. Arch Pediatr Adolesc Med (1999) 2.23

Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology (1986) 2.20

Description of the Genetic Analysis Workshop 11 Collaborative Study on the Genetics of Alcoholism. Genet Epidemiol (1999) 2.01

Protecting seriously mistreated children: time delays in a court sample. Child Abuse Negl (1992) 2.01

Mechanism of action of camptothecin. Ann N Y Acad Sci (2000) 2.01

Hunger in children in the United States: potential behavioral and emotional correlates. Pediatrics (1998) 1.99

The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun (1999) 1.97

Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res (2007) 1.97

Affective disorders and mortality. A general population study. Arch Gen Psychiatry (1987) 1.95

Polymorphism of ADH and ALDH genes among four ethnic groups in China and effects upon the risk for alcoholism. Alcohol Clin Exp Res (1997) 1.79

Maternal and fetal plasma levels of pyridoxal phosphate at term: adequacy of vitamin B6 supplementation during pregnancy. Am J Obstet Gynecol (1975) 1.78

Regulation of alcohol consumption by the renin-angiotensin system: a review of recent findings and a possible mechanism of action. Neurosci Biobehav Rev (1991) 1.72

Elimination of rabies from red foxes in eastern Ontario. J Wildl Dis (2001) 1.70

Multiple informants: mortality associated with psychiatric disorders in the Stirling County Study. Am J Epidemiol (2001) 1.67

Ethanol self-infusion into the ventral tegmental area by alcohol-preferring rats. Alcohol (1995) 1.67

Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells. Cancer Res (2001) 1.63

Diet, breakfast, and academic performance in children. Ann Nutr Metab (2002) 1.61

General dental practitioners' perception of their role within child protection: a qualitative study. Eur J Paediatr Dent (2003) 1.60

Clamping breath alcohol concentration reduces experimental variance: application to the study of acute tolerance to alcohol and alcohol elimination rate. Alcohol Clin Exp Res (1998) 1.58

Brief psychosocial screening in outpatient pediatric practice. J Pediatr (1986) 1.56

Regional heterogeneity for the intracranial self-administration of ethanol within the ventral tegmental area of female Wistar rats. Psychopharmacology (Berl) (2000) 1.55

Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. J Neurosci (1997) 1.55

Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat (2010) 1.54

Self-infusion of GABA(A) antagonists directly into the ventral tegmental area and adjacent regions. Behav Neurosci (1997) 1.54

Selective breeding for high and low alcohol preference in mice. Behav Genet (1999) 1.51

Pediatric Symptom Checklist: screening school-age children for psychosocial dysfunction. J Pediatr (1988) 1.51

A physiologically-based pharmacokinetic (PBPK) model for alcohol facilitates rapid BrAC clamping. Alcohol Clin Exp Res (1999) 1.50

Vitamin B6 metabolism in chronic alcohol abuse. Pyridoxal phosphate levels in plasma and the effects of acetaldehyde on pyridoxal phosphate synthesis and degradation in human erythrocytes. J Clin Invest (1974) 1.49

The Pediatric Symptom Checklist. Support for a role in a managed care environment. Arch Pediatr Adolesc Med (1995) 1.48

A comparison of three psychiatric screening tests using receiver operating characteristic (ROC) analysis. Med Care (1989) 1.48

Psychiatric outcome of burned children and adolescents. J Am Acad Child Adolesc Psychiatry (1989) 1.44

Involvement of nicotinic receptors in alcohol self-administration. Alcohol Clin Exp Res (2000) 1.43

Quantitative trait loci analysis of human event-related brain potentials: P3 voltage. Electroencephalogr Clin Neurophysiol (1998) 1.43

Regional differences within the rat ventral tegmental area for muscimol self-infusions. Pharmacol Biochem Behav (1998) 1.43

Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol (1992) 1.43

Effects of scheduled access on ethanol intake by the alcohol-preferring (P) line of rats. Alcohol (1986) 1.42

Effects of concurrent access to multiple ethanol concentrations and repeated deprivations on alcohol intake of alcohol-preferring rats. Alcohol Clin Exp Res (2001) 1.42

Comparison of alcohol-preferring (P) and nonpreferring (NP) rats on tests of anxiety and for the anxiolytic effects of ethanol. Alcohol (1993) 1.41

The future of pharmacy: Armageddon or Pollyanna? Ann Pharmacother (1995) 1.39

Low frequency of the ADH2*2 allele among Atayal natives of Taiwan with alcohol use disorders. Alcohol Clin Exp Res (1994) 1.38

A quantitative trait locus for alcohol consumption in selectively bred rat lines. Alcohol Clin Exp Res (1998) 1.37

Clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component. Am J Psychiatry (1999) 1.37

Research advances in ethanol metabolism. Pathol Biol (Paris) (2001) 1.37

Genotyping of human alcohol dehydrogenases at the ADH2 and ADH3 loci following DNA sequence amplification. Genomics (1988) 1.37

Progress toward a voluntary oral consumption model of alcoholism. Drug Alcohol Depend (1980) 1.36

Genomic screen for QTLs underlying alcohol consumption in the P and NP rat lines. Mamm Genome (1998) 1.35

Association of the ADH2*2 allele with reduced ethanol consumption in Jewish men in Israel: a pilot study. J Stud Alcohol (1998) 1.35

Alcohol deprivation effect is prolonged in the alcohol preferring (P) rat after repeated deprivations. Alcohol Clin Exp Res (2000) 1.33

Direct measurement of active transport systems for alanine in freshly isolated rat liver cells. Biochem Biophys Res Commun (1977) 1.33

Serum ionized calcium during bed rest in fracture patients and normal men. Metabolism (1972) 1.32

The expression of an alcohol deprivation effect in the high-alcohol-drinking replicate rat lines is dependent on repeated deprivations. Alcohol Clin Exp Res (2000) 1.29

Wide complex tachycardia: misdiagnosis and outcome after emergent therapy. Ann Intern Med (1986) 1.28

Drug interactions and multiple drug administration. Clin Pharmacol Ther (1977) 1.28

Defining alcohol-related phenotypes in humans. The Collaborative Study on the Genetics of Alcoholism. Alcohol Res Health (2002) 1.27

A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm (1973) 1.27

Increased vulnerability to nicotine self-administration and relapse in alcohol-naive offspring of rats selectively bred for high alcohol intake. J Neurosci (2006) 1.26

Involvement of acetaldehyde for full protection against alcoholism by homozygosity of the variant allele of mitochondrial aldehyde dehydrogenase gene in Asians. Pharmacogenetics (1999) 1.25

Psychiatric labeling in cross-cultural perspective. Science (1976) 1.25

Isolation, characterization, and serotyping of Campylobacter jejuni and Campylobacter coli from slaughter cattle. Appl Environ Microbiol (1985) 1.25

Human liver alcohol dehydrogenase: purification and kinetic characterization of the beta 2 beta 2, beta 2 beta 1, alpha beta 2, and beta 2 gamma 1 "Oriental" isoenzymes. Biochemistry (1984) 1.25

Alcohol dehydrogenase polymorphisms influence alcohol-elimination rates in a male Jewish population. Alcohol Clin Exp Res (2004) 1.25

Utility of psychosocial screening at a school-based health center. J Sch Health (2000) 1.25

Rodent lines selected for factors affecting alcohol consumption. Alcohol Alcohol Suppl (1987) 1.23

Isolation of pi-alcohol dehydrogenase of human liver: is it a determinant of alcoholism? Proc Natl Acad Sci U S A (1977) 1.22

Food-deprivation increases cocaine-induced conditioned place preference and locomotor activity in rats. Psychopharmacology (Berl) (1997) 1.22

Prenatal alcohol exposure alters the patterns of facial asymmetry. Alcohol (2010) 1.21

Consumption of sweet, salty, sour, and bitter solutions by selectively bred alcohol-preferring and alcohol-nonpreferring lines of rats. Alcohol Clin Exp Res (1994) 1.20

Studies on the epidemiology of adverse drug reactions. VI. Utilization and interactions of prescription and nonprescription drugs in outpatients. Johns Hopkins Med J (1971) 1.20

Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation. Rheumatology (Oxford) (2008) 1.20

Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients. Hepatology (1994) 1.19

Blocking GABA(A) receptors in the anterior ventral tegmental area attenuates ethanol intake of the alcohol-preferring P rat. Psychopharmacology (Berl) (1998) 1.19

Ethanol drinking and deprivation alter dopaminergic and serotonergic function in the nucleus accumbens of alcohol-preferring rats. J Pharmacol Exp Ther (2004) 1.19